Because of the frequent HLA-B and TAP transcriptional silencing in pediatric tumors, the identification of TAP-independent epitopes could also provide relevant T cell targets, particularly in HLA-A2-positive patients, as reported for TAP-deficient adult tumor cell lines (106) and in preclinical studies (107). This evidence concerns the gene HLA-B and neoplasm.